title: WHO influenza vaccine technology transfer initiative: role and activities of the Technical Advisory Group.
abstract: In May 2006, the WHO published a Global Pandemic Influenza Action Plan. A significant part of that plan involves the transfer of technology necessary to build production capacity in developing countries. The WHO influenza technology transfer initiative has been successful. Clearly the relatively small WHO investments made in these companies to develop their own influenza vaccine production facilities have had quite dramatic results. A few companies are already producing large amounts of influenza vaccine. Others will soon follow. Whether they are developing egg-based or planning non-egg based influenza vaccine production, all companies are optimistic that their efforts will come to fruition.
authors.affiliation: Executive Director Global Solutions for Infectious Diseases, South San Francisco, CA, USA. dfrancis@gsid.org
authors.forename: Donald P
authors.initials: DP
authors.lastname: Francis
authors.forename: Gary
authors.initials: G
authors.lastname: Grohmann
mesh_terms: D003906:Developing Countries; D006801:Humans; D007252:Influenza Vaccines / Q000600:supply & distribution*; D007251:Influenza, Human / Q000517:prevention & control*; D018581:Technology Transfer; D013678:Technology, Pharmaceutical / Q000331:legislation & jurisprudence / Q000379:methods* / Q000458:organization & administration*; D014944:World Health Organization
chemical_list: D007252:Influenza Vaccines